Winthrop Partners - WNY’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
8,416
+65
+0.8% +$18K 0.92% 35
2026
Q1
$2.47M Hold
8,351
1.31% 29
2025
Q4
$2.28M Buy
+8,351
New +$2.27M 1.23% 28
2019
Q3
$1.87M Buy
8,854
+408
+5% +$85.2K 1.26% 27
2019
Q2
$1.64M Buy
8,446
+304
+4% +$56K 1.23% 28
2019
Q1
$1.36M Buy
8,142
+1,006
+14% +$178K 1.06% 33
2018
Q4
$1.34M Buy
7,136
+320
+5% +$59.1K 1.25% 25
2018
Q3
$1.16M Buy
6,816
+1,494
+28% +$252K 0.94% 36
2018
Q2
$872K Buy
5,322
+170
+3% +$27.8K 0.73% 45
2018
Q1
$820K Buy
5,152
+275
+6% +$43.8K 0.63% 47
2017
Q4
$836K Buy
+4,877
New +$695K 0.68% 47

Other funds holding CME

Winthrop Partners - WNY's CME Position: Q2 2026 in Review

Winthrop Partners - WNY increased its CME Group (CME) stake by 0.78% in Q2 2026, buying an estimated $18K and bringing the position to 8,416 shares worth $1.86M. The position accounts for 0.92% of the portfolio, ranked #35.

Winthrop Partners - WNY first reported a position in CME in Q4 2017 and has held it in 11 quarters since. The position peaked at $2.47M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Winthrop Partners - WNY held 8,416 shares of CME Group worth $1.86M as of Q2 2026.
  • Winthrop Partners - WNY bought 65 CME Group shares in Q2 2026, an estimated $18K.
  • CME Group made up 0.92% of Winthrop Partners - WNY's portfolio in Q2 2026, its #35 holding.
  • Winthrop Partners - WNY first reported a position in CME Group in Q4 2017 and has held it in 11 quarters since.
  • Winthrop Partners - WNY's CME Group position peaked at $2.47M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Winthrop Partners - WNY's 13F filing for Q2 2026, filed 15 Jul 2026.